| [1] |
Watanabe TK, Katagiri T, Suzuki M, et al. Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats [J]. Genomics, 1996, 38(3): 273-276.
|
| [2] |
Pakvasa M, Alverdy A, Mostafa S, et al. Neural EGF-like protein 1 (NELL-1): signaling crosstalk in mesenchymal stem cells and applications in regenerative medicine [J]. Genes Dis, 2017, 4(3): 127-137.
|
| [3] |
曹曦，崔伟，陈跃平，等. 尼尔样1型生长因子促进修复骨再生和治疗骨质疏松的应用潜力[J]. 中国组织工程研究，2019, 23(8): 1235-1240.
|
| [4] |
The Human Protein Atlas. NELL1 [DB/OL]. 2019:
URL
|
| [5] |
Hasebe A, Tashima H, Ide T, et al. Efficient production and characterization of recombinant human NELL1 protein in human embryonic kidney 293-F cells [J]. Mol Biotechnoly, 2012, 51(1): 58-56.
|
| [6] |
Nakamura R, Oyama T, Tajiri R, et al. Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma [J]. Cancer Sci, 2015, 106(5): 656-664.
|
| [7] |
Zhang X, Carpenter D, Bokui N, et al. Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development [J]. J Bone Miner Res, 2003, 18(12): 2126-2134.
|
| [8] |
Shen J, James AW, Chung J, et al. NELL-1 promotes cell adhesion and differentiation via integrin β1 [J]. J Cell Biochem, 2012, 113(12): 3620-3628.
|
| [9] |
Li C, Zheng Z, Zhang X, et al. Nfatc1 is a functional transcriptional factor mediating Nell-1-induced Runx3 upregulation in chondrocytes [J]. Int J Mol Sci, 2018, 19(1): 168.
|
| [10] |
Mishra R, Sefcik RS, Bishop TJ, et al. Growth factor dose tuning for bone progenitor cell proliferation and differentiation on resorbable poly(propylene fumarate) scaffolds [J]. Tissue Eng Part C Methods, 2016, 22(9): 904-913.
|
| [11] |
Liu M, Wang Q, Tang R, et al. Nel-like molecule 1 contributes to the odontoblastic differentiation of human dental pulp cells [J]. J Endod, 2016, 42(1): 95-100.
|
| [12] |
James AW, Chiang M, Asatrian G, et al. Vertebral implantation of NELL-1 enhances bone formation in an osteoporotic sheep model [J]. Tissue Eng Part A, 2016, 22(11-12): 840-849.
|
| [13] |
Zhang Y, Velasco O, Zhang X, et al. Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy [J]. Biomaterials, 2014, 35(24): 6614-6621.
|
| [14] |
James AW, Shen J, Zhang X, et al. NELL-1 in the treatment of osteoporotic bone loss [J]. Nat Commun, 2015, 6: 7362.
|
| [15] |
Beck LH Jr, Bonegio RGB, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy [J]. N Engl J Med, 2009, 361(1): 11-21.
|
| [16] |
Bobart SA, De Vriese AS, Pawar AS, et al. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies [J]. Kidney Int, 2019, 95(2): 429-438.
|
| [17] |
Tomas NM, Beck LH, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy [J]. N Engl J Med, 2014, 372(24): 2277-2287.
|
| [18] |
Sethi S, Debiec H, Madden B, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy [J]. Kidney Int, 2020, 97(1): 163-174.
|